Literature DB >> 29905479

MixMD Probeview: Robust Binding Site Prediction from Cosolvent Simulations.

Sarah E Graham, Noah Leja, Heather A Carlson.   

Abstract

Mixed-solvent molecular dynamics (MixMD) is a cosolvent simulation technique for identifying binding hotspots and specific favorable interactions on a protein's surface. MixMD studies have the ability to identify these biologically relevant sites by examining the occupancy of the cosolvent over the course of the simulation. However, previous MixMD analysis required a great deal of manual inspection to identify relevant sites. To address this limitation, we have developed MixMD Probeview as a plugin for the freely available, open-source version of the molecular visualization program PyMOL. MixMD Probeview incorporates two analysis procedures: (1) identifying and ranking whole binding sites and (2) identifying and ranking local maxima for each probe type. These functionalities were validated using four common benchmark proteins, including two with both active and allosteric sites. In addition, three different cosolvent procedures were compared to examine the impact of including more than one cosolvent in the simulations. For all systems tested, MixMD Probeview successfully identified known active and allosteric sites based on the total occupancy of neutral probe molecules. As an easy-to-use PyMOL plugin, we expect that MixMD Probeview will facilitate identification and analysis of binding sites from cosolvent simulations performed on a wide range of systems.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29905479      PMCID: PMC6186161          DOI: 10.1021/acs.jcim.8b00265

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  36 in total

1.  PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data.

Authors:  Daniel R Roe; Thomas E Cheatham
Journal:  J Chem Theory Comput       Date:  2013-06-25       Impact factor: 6.006

2.  Binding site detection and druggability index from first principles.

Authors:  Jesus Seco; F Javier Luque; Xavier Barril
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

3.  Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity.

Authors:  Karine Pereira de Jésus-Tran; Pierre-Luc Côté; Line Cantin; Jonathan Blanchet; Fernand Labrie; Rock Breton
Journal:  Protein Sci       Date:  2006-05       Impact factor: 6.725

4.  The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins.

Authors:  Dima Kozakov; Laurie E Grove; David R Hall; Tanggis Bohnuud; Scott E Mottarella; Lingqi Luo; Bing Xia; Dmitri Beglov; Sandor Vajda
Journal:  Nat Protoc       Date:  2015-04-09       Impact factor: 13.491

5.  Discovery of furo[2,3-d][1,3]thiazinamines as beta amyloid cleaving enzyme-1 (BACE1) inhibitors.

Authors:  Yong-Jin Wu; Jason Guernon; Ramkumar Rajamani; Jeremy H Toyn; Michael K Ahlijanian; Charles F Albright; Jodi Muckelbauer; ChiehYing Chang; Dan Camac; John E Macor; Lorin A Thompson
Journal:  Bioorg Med Chem Lett       Date:  2016-10-20       Impact factor: 2.823

6.  Molecular dynamics simulations of alcohol dehydrogenase with a four- or five-coordinate catalytic zinc ion.

Authors:  U Ryde
Journal:  Proteins       Date:  1995-01

7.  Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine template.

Authors:  Tianjun Zhou; Lois Commodore; Wei-Sheng Huang; Yihan Wang; Tomi K Sawyer; William C Shakespeare; Tim Clackson; Xiaotian Zhu; David C Dalgarno
Journal:  Chem Biol Drug Des       Date:  2009-11-05       Impact factor: 2.817

8.  Structural basis for the autoinhibition of c-Abl tyrosine kinase.

Authors:  Bhushan Nagar; Oliver Hantschel; Matthew A Young; Klaus Scheffzek; Darren Veach; William Bornmann; Bayard Clarkson; Giulio Superti-Furga; John Kuriyan
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Druggability Assessment of Allosteric Proteins by Dynamics Simulations in the Presence of Probe Molecules.

Authors:  Ahmet Bakan; Neysa Nevins; Ami S Lakdawala; Ivet Bahar
Journal:  J Chem Theory Comput       Date:  2012-06-05       Impact factor: 6.006

View more
  9 in total

1.  Application of Site-Identification by Ligand Competitive Saturation in Computer-Aided Drug Design.

Authors:  Himanshu Goel; Anthony Hazel; Wenbo Yu; Sunhwan Jo; Alexander D MacKerell
Journal:  New J Chem       Date:  2021-11-29       Impact factor: 3.591

2.  Mixed-solvent molecular dynamics simulation-based discovery of a putative allosteric site on regulator of G protein signaling 4.

Authors:  Wallace K B Chan; Debarati DasGupta; Heather A Carlson; John R Traynor
Journal:  J Comput Chem       Date:  2021-09-07       Impact factor: 3.672

3.  Impact of electronic polarizability on protein-functional group interactions.

Authors:  Himanshu Goel; Wenbo Yu; Vincent D Ustach; Asaminew H Aytenfisu; Delin Sun; Alexander D MacKerell
Journal:  Phys Chem Chem Phys       Date:  2020-04-06       Impact factor: 3.676

4.  Identification of Cryptic Binding Sites Using MixMD with Standard and Accelerated Molecular Dynamics.

Authors:  Richard D Smith; Heather A Carlson
Journal:  J Chem Inf Model       Date:  2021-02-18       Impact factor: 4.956

5.  Pharmmaker: Pharmacophore modeling and hit identification based on druggability simulations.

Authors:  Ji Young Lee; James M Krieger; Hongchun Li; Ivet Bahar
Journal:  Protein Sci       Date:  2019-12-04       Impact factor: 6.725

6.  Detection of Binding Sites on SARS-CoV-2 Spike Protein Receptor-Binding Domain by Molecular Dynamics Simulations in Mixed Solvents.

Authors:  Elmeri M Jokinen; Krishnasamy Gopinath; Sami T Kurkinen; Olli T Pentikainen
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2021-08-06       Impact factor: 3.702

7.  Fragment Hotspot Mapping to Identify Selectivity-Determining Regions between Related Proteins.

Authors:  Mihaela D Smilova; Peter R Curran; Chris J Radoux; Frank von Delft; Jason C Cole; Anthony R Bradley; Brian D Marsden
Journal:  J Chem Inf Model       Date:  2022-01-12       Impact factor: 4.956

8.  Monte Carlo simulations using PELE to identify a protein-protein inhibitor binding site and pose.

Authors:  Lucía Díaz; Daniel Soler; Gary Tresadern; Christophe Buyck; Laura Perez-Benito; Suwipa Saen-Oon; Victor Guallar; Robert Soliva
Journal:  RSC Adv       Date:  2020-02-17       Impact factor: 3.361

9.  Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability.

Authors:  Yue Qiu; Qing Liu; Gao Tu; Xiao-Jun Yao
Journal:  Int J Mol Sci       Date:  2022-09-24       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.